大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/04/23 | 6,342 | 6,408 | 6,324 | 6,340 | +18 | +0.3% | 653,300 |
2024/04/22 | 6,286 | 6,347 | 6,221 | 6,322 | +136 | +2.2% | 706,700 |
2024/04/19 | 6,160 | 6,210 | 6,066 | 6,186 | -8 | -0.1% | 1,008,800 |
2024/04/18 | 6,239 | 6,292 | 6,186 | 6,194 | -67 | -1.1% | 777,700 |
2024/04/17 | 6,301 | 6,329 | 6,256 | 6,261 | -75 | -1.2% | 643,400 |
2024/04/16 | 6,301 | 6,360 | 6,257 | 6,336 | -10 | -0.2% | 921,200 |
2024/04/15 | 6,300 | 6,391 | 6,270 | 6,346 | -40 | -0.6% | 688,400 |
2024/04/12 | 6,392 | 6,415 | 6,311 | 6,386 | +81 | +1.3% | 1,036,400 |
2024/04/11 | 6,250 | 6,314 | 6,205 | 6,305 | -23 | -0.4% | 961,900 |
2024/04/10 | 6,363 | 6,386 | 6,304 | 6,328 | +65 | +1% | 837,600 |
2024/04/09 | 6,250 | 6,282 | 6,204 | 6,263 | -6 | -0.1% | 615,100 |
2024/04/08 | 6,230 | 6,306 | 6,224 | 6,269 | +51 | +0.8% | 834,800 |
2024/04/05 | 6,220 | 6,245 | 6,137 | 6,218 | -98 | -1.6% | 1,335,900 |
2024/04/04 | 6,350 | 6,398 | 6,294 | 6,316 | -33 | -0.5% | 1,109,200 |
2024/04/03 | 6,369 | 6,408 | 6,283 | 6,349 | -21 | -0.3% | 1,358,300 |
2024/04/02 | 6,368 | 6,430 | 6,329 | 6,370 | +37 | +0.6% | 1,181,300 |
2024/04/01 | 6,324 | 6,373 | 6,275 | 6,333 | +23 | +0.4% | 557,500 |
2024/03/29 | 6,315 | 6,329 | 6,248 | 6,310 | +39 | +0.6% | 1,107,900 |
2024/03/28 | 6,379 | 6,414 | 6,251 | 6,271 | -111 | -1.7% | 1,106,800 |
2024/03/27 | 6,300 | 6,418 | 6,290 | 6,382 | +93 | +1.5% | 1,197,500 |
2024/03/26 | 6,262 | 6,312 | 6,212 | 6,289 | -29 | -0.5% | 764,300 |
2024/03/25 | 6,480 | 6,480 | 6,310 | 6,318 | -150 | -2.3% | 873,200 |
2024/03/22 | 6,431 | 6,510 | 6,429 | 6,468 | +60 | +0.9% | 1,116,000 |
2024/03/21 | 6,407 | 6,431 | 6,352 | 6,408 | +82 | +1.3% | 1,146,200 |
2024/03/19 | 6,280 | 6,326 | 6,192 | 6,326 | +2 | ±0% | 1,278,500 |
2024/03/18 | 6,150 | 6,360 | 6,149 | 6,324 | +264 | +4.4% | 1,199,800 |
2024/03/15 | 6,030 | 6,113 | 6,010 | 6,060 | +63 | +1.1% | 1,209,200 |
2024/03/14 | 5,994 | 6,052 | 5,960 | 5,997 | -9 | -0.1% | 1,113,600 |
2024/03/13 | 5,995 | 6,008 | 5,938 | 6,006 | +24 | +0.4% | 988,300 |
2024/03/12 | 6,000 | 6,006 | 5,895 | 5,982 | +25 | +0.4% | 996,200 |
2024/03/11 | 6,016 | 6,023 | 5,855 | 5,957 | -121 | -2% | 1,160,200 |
2024/03/08 | 6,000 | 6,078 | 5,927 | 6,078 | +78 | +1.3% | 1,667,900 |
2024/03/07 | 6,019 | 6,074 | 5,972 | 6,000 | -26 | -0.4% | 1,053,600 |
2024/03/06 | 6,089 | 6,120 | 6,019 | 6,026 | -53 | -0.9% | 1,117,800 |
2024/03/05 | 6,004 | 6,088 | 6,001 | 6,079 | +34 | +0.6% | 888,900 |
2024/03/04 | 6,006 | 6,093 | 6,004 | 6,045 | -9 | -0.1% | 980,400 |
2024/03/01 | 6,059 | 6,096 | 6,011 | 6,054 | -28 | -0.5% | 756,800 |
2024/02/29 | 6,147 | 6,169 | 6,055 | 6,082 | -70 | -1.1% | 1,335,900 |
2024/02/28 | 6,088 | 6,173 | 6,063 | 6,152 | +78 | +1.3% | 1,356,600 |
2024/02/27 | 5,840 | 6,087 | 5,840 | 6,074 | +302 | +5.2% | 2,271,000 |
2024/02/26 | 5,683 | 5,814 | 5,683 | 5,772 | +134 | +2.4% | 1,237,200 |
2024/02/22 | 5,584 | 5,678 | 5,580 | 5,638 | +42 | +0.8% | 995,400 |
2024/02/21 | 5,559 | 5,623 | 5,542 | 5,596 | +37 | +0.7% | 993,400 |
2024/02/20 | 5,527 | 5,625 | 5,506 | 5,559 | +47 | +0.9% | 862,000 |
2024/02/19 | 5,574 | 5,624 | 5,495 | 5,512 | -90 | -1.6% | 806,200 |
2024/02/16 | 5,482 | 5,661 | 5,482 | 5,602 | +174 | +3.2% | 1,735,600 |
2024/02/15 | 5,440 | 5,506 | 5,338 | 5,428 | -6 | -0.1% | 2,480,200 |
2024/02/14 | 5,410 | 5,614 | 5,261 | 5,434 | +75 | +1.4% | 3,347,500 |
2024/02/13 | 5,044 | 5,359 | 5,030 | 5,359 | -285 | -5% | 3,274,800 |
2024/02/09 | 5,646 | 5,777 | 5,623 | 5,644 | -14 | -0.2% | 1,397,900 |
251~
300
件表示中 / 3518件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
第一三共 | 370,200円 | +6.0% | +4.0% | 2.11% | 22.98倍 | 4.25倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
武 田 | 441,900円 | +7.7% | +206.9% | 4.44% | 59.10倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 245,700円 | +5.7% | +3.9% | 2.50% | 12.22倍 | 1.62倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム